P04 - Newborn (suspected to be) affected by noxious substances transmitted via placenta or breast milk
Includes:
-nonteratogenic effects of substances transmitted via placenta
Excludes 2:
-congenital malformations (Q00-Q99)
-neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother P58.4)
-newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
P04.0 - Newborn (suspected to be) affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
P04.1 - Newborn (suspected to be) affected by other maternal medication
P04.2 - Newborn (suspected to be) affected by maternal use of tobacco
P04.3 - Newborn (suspected to be) affected by maternal use of alcohol
P04.4 - Newborn (suspected to be) affected by maternal use of drugs of addiction
P04.41 - Newborn (suspected to be) affected by maternal use of cocaine
P04.49 - Newborn (suspected to be) affected by maternal use of other drugs of addiction
P04.5 - Newborn (suspected to be) affected by maternal use of nutritional chemical substances
P04.6 - Newborn (suspected to be) affected by maternal exposure to environmental chemical substances
P04.8 - Newborn (suspected to be) affected by other maternal noxious substances
P04.9 - Newborn (suspected to be) affected by maternal noxious substance, unspecified